Skip to main content
. 2023 Jan 11;11(1):182. doi: 10.3390/microorganisms11010182

Table 2.

Different treatments on the CFS of L. animalis SWLA-1 and residual antimicrobial activity.

Treatment Condition Final pH Residual Antimicrobial Activity (%)
Concentration S. gallinarum S. enteritidis E. coli S. aureus
 CFS (1×) None 5.1 100 ±   0.0 100 ±   0.0 100 ±   0.0 100 ±   0.0
 Concentrated (10×) Lyophilized, 24 h 5.1 400 ±   0.0 400 ±   0.0 400 ±   0.0 400 ±   0.0
Temperature
 40 °C Heated, 2 h 5.1 100 ±   0.0 100 ±   0.0 100 ±   0.0 100 ±   0.0
 60 °C Heated, 2 h 5.1 100 ±   0.0 100 ±   0.0 100 ±   0.0 100 ±   0.0
 80 °C Heated, 2 h 5.1 100 ±   0.0 100 ± 16.7 100 ±   0.0 100 ±   0.0
 100 °C Heated, 30 min 5.1 83.3 ± 16.7 83.3 ± 16.7 100 ±   0.0 100 ±   0.0
pH
 2.0 Exposure to pH 2 at 37 °C, 2 h 6.8 50 ±   0.0 50 ±   0.0 50 ±   0.0 50 ±   0.0
 4.0 Exposure to pH 4 at 37 °C, 2 h 6.8 50 ±   0.0 50 ±   0.0 50 ±   0.0 50 ±   0.0
 6.0 Exposure to pH 6 at 37 °C, 2 h 6.8 50 ±   0.0 25 ±   0.0 50 ±   0.0 50 ±   0.0
 8.0 Exposure to pH 8 at 37 °C, 2 h 6.8 50 ±   0.0 25 ±   0.0 50 ±   0.0 50 ±   0.0
Enzyme
 Proteinase K 2 mg/mL at 37 °C, 2 h 5.1 100 ±   0.0 66.7 ± 16.7 100 ±   0.0 100 ±   0.0
 Trypsin 1 mg/mL at 37 °C, 2 h 5.1 83.3 ± 16.7 66.7 ± 16.7 83.3 ± 16.7 83.3 ± 16.7

Each value is presented as the mean ± standard deviation.